H.R. 6860 118th Congress
Restore Protections for Dialysis Patients Act
- Health
- Sponsor: Rep. Kelly, Mike [R-PA-16]
- Congress.gov ↗
Latest action, Dec 17, 2024: Referred to the Subcommittee on Health.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
53 cosponsors
Sponsored by Rep. Kelly, Mike [R-PA-16] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
34 D · 19 R
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
AMERICAN NEPHROLOGY NURSES ASSOCIATION
VENABLE LLP
5 reports
DAVITA INC
CAPITOL HILL CONSULTING GROUP
5 reports
5 reports
DAVITA INC.
WEST FRONT STRATEGIES LLC
5 reports
5 reports
5 reports
FRESENIUS MEDICAL CARE NORTH AMERICA
AVENUE SOLUTIONS
5 reports
FRESENIUS MEDICAL CARE NORTH AMERICA
FEDERAL HEALTH POLICY STRATEGIES
5 reports
KIDNEY CARE COUNCIL
LESTER HEALTH LAW PLLC
5 reports
KIDNEY CARE PARTNERS
FEDERAL HEALTH POLICY STRATEGIES
5 reports
KIDNEY CARE PARTNERS
AVENUE SOLUTIONS
5 reports
KIDNEY CARE PARTNERS
LESTER HEALTH LAW PLLC
5 reports
U.S. RENAL CARE
JEFFREY J. KIMBELL & ASSOCIATES, INC.
5 reports
4 reports
All 25 of 41 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN NEPHROLOGY NURSES ASSOCIATION | VENABLE LLP | 5 | $150K | Q4 2023 | Q3 2024 | yes |
| DAVITA INC | CAPITOL HILL CONSULTING GROUP | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| DAVITA INC | 5 | $5.2M | Q4 2023 | Q3 2024 | yes | |
| DAVITA INC. | WEST FRONT STRATEGIES LLC | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| DIALYSIS PATIENT CITIZENS | 5 | $1.9M | Q4 2023 | Q3 2024 | yes | |
| FRESENIUS MEDICAL CARE NORTH AMERICA | 5 | $8.3M | Q4 2023 | Q3 2024 | yes | |
| FRESENIUS MEDICAL CARE NORTH AMERICA | AVENUE SOLUTIONS | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| FRESENIUS MEDICAL CARE NORTH AMERICA | FEDERAL HEALTH POLICY STRATEGIES | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| KIDNEY CARE COUNCIL | LESTER HEALTH LAW PLLC | 5 | $0 | Q4 2023 | Q3 2024 | yes |
| KIDNEY CARE PARTNERS | FEDERAL HEALTH POLICY STRATEGIES | 5 | $160K | Q4 2023 | Q3 2024 | yes |
| KIDNEY CARE PARTNERS | AVENUE SOLUTIONS | 5 | $350K | Q4 2023 | Q3 2024 | yes |
| KIDNEY CARE PARTNERS | LESTER HEALTH LAW PLLC | 5 | $300K | Q4 2023 | Q3 2024 | yes |
| U.S. RENAL CARE | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 5 | $250K | Q4 2023 | Q3 2024 | yes |
| AKEBIA THERAPEUTICS, INC. | 4 | $1.1M | Q1 2024 | Q3 2024 | yes | |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 4 | $11.8M | Q1 2024 | Q3 2024 | yes | |
| AMERICAN SOCIETY OF NEPHROLOGY | 4 | $320K | Q4 2023 | Q3 2024 | yes | |
| CHAMBER OF COMMERCE OF THE U.S.A. | 4 | $74.5M | Q1 2024 | Q3 2024 | yes | |
| DAVITA INC | AVOQ, LLC | 4 | $0 | Q1 2024 | Q3 2024 | yes |
| DAVITA INC. | RED+BLUE STRATEGIES | 4 | $0 | Q1 2024 | Q3 2024 | yes |
| DAVITA, INC. | FEDERAL STREET STRATEGIES, LLC | 4 | $0 | Q1 2024 | Q3 2024 | yes |
| DIALYSIS PATIENT CITIZENS | KOUNTOUPES DENHAM CARR & REID, LLC | 4 | $0 | Q1 2024 | Q3 2024 | yes |
| NATIONAL KIDNEY FOUNDATION | 4 | $485K | Q1 2024 | Q3 2024 | yes | |
| PARTNERSHIP FOR EMPLOYER-SPONSORED COVERAGE | TRAUTWEIN & ASSOCIATES, LLC | 4 | $75K | Q1 2024 | Q3 2024 | yes |
| SERVICE EMPLOYEES INTERNATIONAL UNION | NVG, LLC | 4 | $560K | Q1 2024 | Q3 2024 | yes |
| SERVICE EMPLOYEES INTERNATIONAL UNION CTW-CLC | 4 | $940K | Q1 2024 | Q3 2024 | yes |